Frontiers in Oncology (May 2022)

Potential Molecular Mechanisms of Recurrent and Progressive Meningiomas: A Review of the Latest Literature

  • Wenjie Peng,
  • Pei Wu,
  • Minghao Yuan,
  • Bo Yuan,
  • Lian Zhu,
  • Jiesong Zhou,
  • Qian Li

DOI
https://doi.org/10.3389/fonc.2022.850463
Journal volume & issue
Vol. 12

Abstract

Read online

Meningiomas, the most frequent primary intracranial tumors of the central nervous system in adults, originate from the meninges and meningeal spaces. Surgical resection and adjuvant radiation are considered the preferred treatment options. Although most meningiomas are benign and slow-growing, some patients suffer from tumor recurrence and disease progression, eventually resulting in poorer clinical outcomes, including malignant transformation and death. It is thus crucial to identify these “high-risk” tumors early; this requires an in-depth understanding of the molecular and genetic alterations, thereby providing a theoretical foundation for establishing personalized and precise treatment in the future. Here, we review the most up-to-date knowledge of the cellular biological alterations involved in the progression of meningiomas, including cell proliferation, neo-angiogenesis, inhibition of apoptosis, and immunogenicity. Focused genetic alterations, including chromosomal abnormalities and DNA methylation patterns, are summarized and discussed in detail. We also present latest therapeutic targets and clinical trials for meningiomas' treatment. A further understanding of cellular biological and genetic alterations will provide new prospects for the accurate screening and treatment of recurrent and progressive meningiomas.

Keywords